TR201910287T4 - Tetrahidrobiopterin ihtiva eden farmasötik dozaj şekli. - Google Patents

Tetrahidrobiopterin ihtiva eden farmasötik dozaj şekli. Download PDF

Info

Publication number
TR201910287T4
TR201910287T4 TR2019/10287T TR201910287T TR201910287T4 TR 201910287 T4 TR201910287 T4 TR 201910287T4 TR 2019/10287 T TR2019/10287 T TR 2019/10287T TR 201910287 T TR201910287 T TR 201910287T TR 201910287 T4 TR201910287 T4 TR 201910287T4
Authority
TR
Turkey
Prior art keywords
dosage form
pharmaceutical dosage
tetrahydrobiopterin
form containing
aqueous solution
Prior art date
Application number
TR2019/10287T
Other languages
English (en)
Turkish (tr)
Inventor
Widmann Rudolf
Bernkop-Schnuerch Andreas
Original Assignee
Orpha Swiss Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orpha Swiss Gmbh filed Critical Orpha Swiss Gmbh
Publication of TR201910287T4 publication Critical patent/TR201910287T4/tr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
TR2019/10287T 2008-08-12 2009-08-07 Tetrahidrobiopterin ihtiva eden farmasötik dozaj şekli. TR201910287T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT12542008 2008-08-12

Publications (1)

Publication Number Publication Date
TR201910287T4 true TR201910287T4 (tr) 2019-07-22

Family

ID=41111155

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/10287T TR201910287T4 (tr) 2008-08-12 2009-08-07 Tetrahidrobiopterin ihtiva eden farmasötik dozaj şekli.

Country Status (8)

Country Link
US (1) US20110144117A1 (enExample)
EP (1) EP2309983B1 (enExample)
JP (1) JP2011530540A (enExample)
ES (1) ES2736730T3 (enExample)
PL (1) PL2309983T3 (enExample)
RU (1) RU2011109210A (enExample)
TR (1) TR201910287T4 (enExample)
WO (1) WO2010017570A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014202925B2 (en) * 2013-01-10 2015-07-09 Nutritional Therapeutics, Inc. Chewable wafers containing lipid supplements for maintaining health and the treatment of acute and chronic disorders
EP2926805B1 (en) 2014-03-31 2016-05-18 Vasopharm GmbH Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
IL266955B2 (en) 2016-11-29 2023-09-01 Ptc Therapeutics Mp Inc Polymorphs of spiafatrin and its salts
WO2018102314A1 (en) 2016-11-29 2018-06-07 Censa Pharmaceuticals Inc. Polymorphic form of sepiapterin
WO2019046849A1 (en) * 2017-09-01 2019-03-07 Censa Pharmaceuticals Inc. PHARMACEUTICAL COMPOSITION COMPRISING SEPAPTERINE AND USES THEREOF
SMT202400430T1 (it) 2018-05-30 2024-11-15 Ptc Therapeutics Mp Inc Somministrazione di sepiapterina, senza alcun alimento, per uso in un metodo per incrementare l’esposizione plasmatica di sepiapterina
EP3801534A4 (en) 2018-05-30 2022-03-16 PTC Therapeutics MP, Inc. COMPOSITIONS AND METHODS TO INCREASE TETRAHYDROBIOPTERIN PLASMA EXPOSURE
JP7553906B2 (ja) * 2018-11-01 2024-09-19 宏 一瀬 Sprをコードするポリヌクレオチドを含む組換えベクター、及びそれを含む組成物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61277618A (ja) * 1985-06-04 1986-12-08 Suntory Ltd 自閉症治療剤
JP2588191B2 (ja) * 1987-04-24 1997-03-05 サントリー株式会社 悪性腫瘍および重症ウイルス感染症に伴う神経症状を改善するための治療剤
DE10260263A1 (de) * 2002-12-20 2004-07-15 Biocrates Life Sciences Gmbh Verwendung von Tetrahydrobiopterinderivaten zur Behandlung und Ernährung von Patienten mit Aminosäurestoffwechselstörungen
WO2005107759A1 (ja) * 2004-05-11 2005-11-17 Daiichi Asubo Pharma Co., Ltd. Bh4反応性高フェニルアラニン血症治療剤
EP2436379A1 (en) * 2004-11-17 2012-04-04 BioMarin Pharmaceutical Inc. Stable tablet formulation
US20060188492A1 (en) * 2005-01-13 2006-08-24 Chronorx Llc, An Alaska Limited Liability Company Topical management of ocular and periocular conditions
AU2006245770A1 (en) * 2005-05-11 2006-11-16 Nycomed Gmbh Combination of the PDE4 inhibitor roflumilast and a tetrahydrobiopterin derivative
DK3461503T3 (da) * 2007-04-11 2022-02-14 Biomarin Pharm Inc Fremgangsmåder til indgivelse af tetrahydrobiopterin, associerede sammensætninger og målingsfremgangsmåder

Also Published As

Publication number Publication date
US20110144117A1 (en) 2011-06-16
WO2010017570A2 (de) 2010-02-18
EP2309983B1 (de) 2019-04-24
JP2011530540A (ja) 2011-12-22
RU2011109210A (ru) 2012-09-20
PL2309983T3 (pl) 2019-09-30
ES2736730T3 (es) 2020-01-07
EP2309983A2 (de) 2011-04-20
WO2010017570A3 (de) 2010-08-05

Similar Documents

Publication Publication Date Title
TR201910287T4 (tr) Tetrahidrobiopterin ihtiva eden farmasötik dozaj şekli.
TW200722005A (en) Oral care implement having reservoir for dispensing active agent
TN2012000371A1 (en) Pyrazole compounds as crth2 antagonists
MX341433B (es) Composicion antitranspirante/desodorante anhidra liquida.
MX2020011961A (es) Formas de dosis de liberacion controlada para substancias de farmaco de alta dosis, solubles en agua e higroscopicas.
WO2014102613A3 (en) Device for disposal and neutralization of pharmaceutical agents
MX2010005385A (es) Medicamentos topicos para la terapia antimicotica.
MX2010009759A (es) Dispositivo dosificador.
MX2013008647A (es) Metodo, composiciones y empaque para limpieza del intestino.
SI2370327T1 (sl) Kartuša, farmacevtski razdeljevalnik, ki omenjeno kartušo vsebuje in uporabe omenjene kartuše in omenjenega farmacevtskga razdeljevalnika
AR063709A1 (es) Diposicion de dosificacion de cafe y te
WO2010131887A2 (ko) 탈모 방지 또는 육모 촉진을 위한 조성물
EA201500376A1 (ru) Композиция для ухода за полостью рта
CO6592109A2 (es) Nueva forma cristalina de un derivado de ciclopropilbenzamida
MY163012A (en) Pyrazole compounds as crth2 antagonists
HRP20150815T1 (hr) Stabilna formulacija injektibilnog paracetamola spremna za uporabu
CO6700853A2 (es) Formulación granular estable durante el almacenamiento y proceso para la formulacíón del mismo
IT1400708B1 (it) Dispositivo per la ricostituzione dosata e la somministrazione di soluzioni liquide contenenti sostanze attive disponibili in forma separata, in particolare in polvere o gel.
PH12015500374A1 (en) Extended release compositions of an aminoalkyl nitrate
FR2967894B1 (fr) Dispositif de conditionnement, de conservation et de preparation extemporanee d'un ou plusieurs principe(s) actif(s).
EA201301021A1 (ru) Применение пригодной для распыления композиции, содержащей амброксол
JP2013147480A5 (enExample)
BR112015000647A2 (pt) composições orais líquidas e pediátricas que contêm nepadutant
EA201590732A1 (ru) Диспергируемая таблетка
FR2928538B1 (fr) Dispositif de conditionnement et d'administration orale d'un medicament sous forme liquide, et pipette de dosage constitutive.